Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs.
Shoko Noda-NaritaAkihiko ShimomuraYuko TanabeJumpei KawauchiJuntaro MatsuzakiSatoko TakizawaYoshiaki AokiChikako ShimizuKenji TamuraTakahiro OchiyaPublished in: BMJ supportive & palliative care (2020)
MiR-451a could be a predictive marker for PN caused by paclitaxel-containing chemotherapy; however, further investigation of the underlying mechanism is required to determine the role of miR-451a.